These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 8214797)

  • 1. Drug therapy for human immunodeficiency virus infection.
    Landor M
    Ann Allergy; 1993 Oct; 71(4):341-6, 349-51; quiz 347, 351-352A. PubMed ID: 8214797
    [No Abstract]   [Full Text] [Related]  

  • 2. Recombinant human erythropoietin treatment: investigational new drug protocol for the anemia of the acquired immunodeficiency syndrome. Overall results.
    Phair JP; Abels RI; McNeill MV; Sullivan DJ
    Arch Intern Med; 1993 Dec; 153(23):2669-75. PubMed ID: 8250662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Double-blind dose-response study of zidovudine in AIDS and advanced HIV infection. Nordic Medical Research Councils' HIV Therapy Group].
    Ugeskr Laeger; 1993 Jan; 155(2):104-7. PubMed ID: 8421854
    [No Abstract]   [Full Text] [Related]  

  • 4. Antiretroviral therapy for infection due to human immunodeficiency virus in children.
    Pizzo PA; Wilfert C
    Pediatr AIDS HIV Infect; 1994 Oct; 5(5):273-95. PubMed ID: 11361369
    [No Abstract]   [Full Text] [Related]  

  • 5. Myocardial risk factors other than human immunodeficiency virus infection may contribute to histologic cardiomyopathic changes in acquired immune deficiency syndrome.
    Segal BH; Factor SM
    Mod Pathol; 1993 Sep; 6(5):560-4. PubMed ID: 8248112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brazilian response to the human immunodeficiency virus/acquired immunodeficiency syndrome epidemic among injection drug users.
    Mesquita F; Doneda D; Gandolfi D; Nemes MI; Andrade T; Bueno R; Piconez e Trigueiros D
    Clin Infect Dis; 2003 Dec; 37 Suppl 5():S382-5. PubMed ID: 14648452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A plea for an individualized therapy regimen. Which is the optimal dose?].
    MMW Fortschr Med; 2002 Apr; 144 Suppl 1():26-7. PubMed ID: 12043067
    [No Abstract]   [Full Text] [Related]  

  • 8. [Antiretroviral therapy. A brief profile of all available drugs].
    Jablonowski H
    MMW Fortschr Med; 2000 Mar; 142 Suppl 1():18-29. PubMed ID: 10863306
    [No Abstract]   [Full Text] [Related]  

  • 9. Human immunodeficiency virus/acquired immune deficiency syndrome-related drug therapy: anesthetic implications.
    Griffis CA
    CRNA; 1999 Aug; 10(3):107-16. PubMed ID: 10723287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotypic changes in drug susceptibility associated with failure of human immunodeficiency virus type 1 (HIV-1) triple combination therapy.
    Parkin NT; Lie YS; Hellmann N; Markowitz M; Bonhoeffer S; Ho DD; Petropoulos CJ
    J Infect Dis; 1999 Sep; 180(3):865-70. PubMed ID: 10438382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sulfated polymannuroguluronate, a novel anti-acquired immune deficiency syndrome drug candidate, blocks neuroinflammatory signalling by targeting the transactivator of transcription (Tat) protein.
    Hui B; Xia W; Li J; Wang L; Ai J; Geng M
    J Neurochem; 2006 Apr; 97(2):334-44. PubMed ID: 16539678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review. Drug resistance of human immunodeficiency virus and overcoming it by natural products.
    Hupfeld J; Efferth T
    In Vivo; 2009; 23(1):1-6. PubMed ID: 19368117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Managing side effects. Individualized dosage makes indinavir more tolerable].
    MMW Fortschr Med; 2003 Apr; 145 Spec No 1():84. PubMed ID: 15011605
    [No Abstract]   [Full Text] [Related]  

  • 14. [AIDS triple therapy. The gap between viral load and side effects].
    Gürtler L
    Fortschr Med; 1998 Sep; 116(27):4-5. PubMed ID: 9816747
    [No Abstract]   [Full Text] [Related]  

  • 15. Starting, stopping, picking, and switching antiretrovirals or, the ring in the river. Glasgow: Part 2.
    Mascolini M
    IAPAC Mon; 2001 Feb; 7(2):54-66. PubMed ID: 11302030
    [No Abstract]   [Full Text] [Related]  

  • 16. [Imuthiol and human immunodeficiency virus infection].
    Lang JM
    Rev Prat; 1989 May; 39(14):1226-7. PubMed ID: 2544023
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of commencing combination antiretroviral therapy soon after human immunodeficiency virus type 1 infection on viral replication and antiviral immune responses.
    Markowitz M; Vesanen M; Tenner-Racz K; Cao Y; Binley JM; Talal A; Hurley A; Jin X; Chaudhry MR; Yaman M; Frankel S; Heath-Chiozzi M; Leonard JM; Moore JP; Racz P; Nixon DF; Ho DD
    J Infect Dis; 1999 Mar; 179(3):527-37. PubMed ID: 9952358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low dose methotrexate, bleomycin, doxorubicin, cyclophosphamide, vincristine, and dexamethasone with zalcitabine in patients with acquired immunodeficiency syndrome-related lymphoma. Effect on human immunodeficiency virus and serum interleukin-6 levels over time.
    Levine AM; Tulpule A; Espina B; Boswell W; Buckley J; Rasheed S; Stain S; Parker J; Nathwani B; Gill PS
    Cancer; 1996 Aug; 78(3):517-26. PubMed ID: 8697399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sarcoidosis in a patient with acquired immunodeficiency syndrome treated with interleukin-2.
    Blanche P; Gombert B; Rollot F; Salmon D; Sicard D
    Clin Infect Dis; 2000 Dec; 31(6):1493-4. PubMed ID: 11096018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of plasma virus load below the detection limit of a human immunodeficiency virus kit is associated with longer virologic response than suppression below the limit of quantitation.
    Raboud JM; Rae S; Hogg RS; Yip B; Sherlock CH; Harrigan PR; O'Shaughnessy MV; Montaner JS
    J Infect Dis; 1999 Oct; 180(4):1347-50. PubMed ID: 10479170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.